Vir Biotechnology, Inc.
VIR
$5.63
-$0.44-7.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -163.14M | -110.96M | -120.97M | -104.59M | -213.72M |
| Total Depreciation and Amortization | 3.00M | 2.92M | 2.87M | 2.89M | 2.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.17M | 12.88M | 13.92M | 31.07M | 21.85M |
| Change in Net Operating Assets | -20.60M | -25.06M | 26.06M | -17.00M | 17.49M |
| Cash from Operations | -167.57M | -120.22M | -78.12M | -87.64M | -171.48M |
| Capital Expenditure | -317.00K | -2.54M | -1.63M | -2.41M | -2.77M |
| Sale of Property, Plant, and Equipment | 37.00K | 45.00K | 281.00K | 2.46M | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.73M | 58.95M | 128.17M | 140.69M | 121.37M |
| Cash from Investing | 40.45M | 56.46M | 126.82M | 140.74M | 118.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 178.00K | -- |
| Issuance of Common Stock | 101.00K | 2.41M | 598.00K | 1.25M | 71.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.00K | -360.00K | -- | -165.00K | -40.00K |
| Cash from Financing | 102.00K | 2.05M | 598.00K | 1.26M | 31.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -127.02M | -61.72M | 49.30M | 54.37M | -52.85M |